Cascades Inc (OTCPK:CADNF)
$ 12.2 +1.15 (+10.41%) Market Cap: 1.23 Bil Enterprise Value: 2.61 Bil PE Ratio: 17.02 PB Ratio: 0.98 GF Score: 71/100

Q2 2026 Cascades Inc. Earnings Call Transcript

Aug 6, 2026 / 01:00 PM GMT
Release Date Price: $11.05 (+8.74%)

Key Points

Positve
  • Cascades Inc (CADNF) reported Q2 2026 results that exceeded expectations, with packaging segment EBITDA increasing 16% sequentially and margins returning above 15%.
  • The company achieved record production levels at its Greenback and Bear Island facilities, with Bear Island operating at 95% of total capacity and showing further improvement in July.
  • Cascades Inc (CADNF) is gaining market share, with box shipments increasing 5.8% year-over-year on a comparable asset basis, surpassing the industry's 2.4% increase.
  • The company is confident in its outlook, expecting annual run-rate adjusted EBITDA to exceed $600 million in the second half of 2026, driven by seasonally higher volumes and ongoing price increases.
  • Cascades Inc (CADNF) has a strong liquidity position with $737 million available under its credit facility and has successfully extended debt maturities, reinforcing its financial flexibility.
  • The company's profitability improvement program is delivering results, with an additional $25 million in benefits expected in 2026, following $30 million realized in 2025.
  • Cascades Inc (CADNF) is progressing well on its asset monetization strategy, having realized $163 million against its $230 million target, with proceeds used for debt reduction.
Negative
  • Cascades Inc (CADNF) faces significant raw material cost inflation, with recycled fiber prices increasing over 10% sequentially and hardwood pulp/eucalyptus costs rising by as much as 15%.
  • The company is exposed to new US tariffs announced in July 2026, which could impact certain tissue and packaging products exported to the United States, potentially affecting up to 5% of adjusted EBITDA.
  • Cascades Inc (CADNF) has delayed its asset monetization objective to early 2027 due to prevailing market conditions not aligning with value expectations, indicating potential friction in the sales process.
  • The tissue segment continues to face margin pressure, with adjusted EBITDA declining $3 million year-over-year due to higher logistics costs, despite volume growth and pricing initiatives.
  • The company's leverage ratio remains elevated at 3.3 times, and net debt was negatively impacted by a $36 million exchange rate effect during the quarter.
  • Cascades Inc (CADNF) faces ongoing macroeconomic and geopolitical uncertainty, which could lead to weaker customer demand or reduced production levels in certain segments.
  • The company's tissue segment margins remain low at 8.6%, reflecting continued cost inflation that is offsetting volume and pricing gains.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CAS.TO - Cascades Inc.
Q2 2026 Cascades Inc. Earnings Call
Aug 06, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Male conference decascade telephonist.

Am com.

Good morning.

My name is Sylvie, and I will be your conference operator today.

At this time, I would like to welcome everyone tosca, second quarter, 2026s conference call.

All lines are currently in a listen-only mode.

After the speaker's remarks, there will be a question-and-answer session.

I will now pass the call to Alan Hogg, CFO for Cascade.

Please go ahead sir you may begin.

Thank you operator.

Good morning everyone, and thank you for joining our second quarter 2026 conference call.

We will begin with an overview of our operational and financial results, followed by some concluding remarks,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot